retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity There's a new drug going viral on social media called Retatrutide. It's currently in Stage 3 of clinical trials and not yet licensed anywhere in the world, but that's not stopped people Retatrutide Explained: The Triple Agonist
Pay in 4 interest-free payments of $7.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10




























